Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Perco

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Plos One|May 15, 2015
A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetesMichelle J Pena, Andreas Heinzel, Georg Heinze, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2016
Metallothioneins and renal ageingJohannes Leierer, Michael Rudnicki, Susie-Jane Braniff, et al.
Human Genomics|December 14, 2011
In-silico human genomics with GeneCardsGil Stelzer, Irina Dalah, Tsippi Iny Stein, et al.
Kidney International Reports|May 2, 2022
Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control StudySara Denicolò, Verena Vogi, Felix Keller, et al.
Hypertension (Dallas, Tex. : 1979)|June 28, 2017
Proteomic-Biostatistic Integrated Approach for Finding the Underlying Molecular Determinants of Hypertension in Human PlasmaPrathibha R Gajjala, Vera Jankowski, Georg Heinze, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 23, 2009
Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustionPaul Jennings, Sonia Aydin, Jason Bennett, et al.
Diabetes Care|July 8, 2018
Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 DiabetesAndreas Heinzel, Michael Kammer, Gert Mayer, et al.
Cancer Letters|June 1, 2019
Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancerCaroline Kreuzinger, Isabel von der Decken, Andrea Wolf, et al.
Nature Communications|February 7, 2026
Urinary clusterin as a biomarker of human kidney disease progression and response to the endothelin receptor antagonist atrasentan: An exploratory analysis from the SONAR trialWenjun Ju, Viji Nair, Priya Vart, et al.
Kidney & Blood Pressure Research|November 7, 2024
Association of Urinary Epidermal Growth Factor, Fatty Acid-Binding Protein 3, and Vascular Cell Adhesion Molecule 1 Levels with the Progression of Early Diabetic Kidney DiseaseFelix Keller, Sara Denicolò, Johannes Leierer, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Plos One|May 15, 2015
A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetesMichelle J Pena, Andreas Heinzel, Georg Heinze, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2016
Metallothioneins and renal ageingJohannes Leierer, Michael Rudnicki, Susie-Jane Braniff, et al.
Human Genomics|December 14, 2011
In-silico human genomics with GeneCardsGil Stelzer, Irina Dalah, Tsippi Iny Stein, et al.
Kidney International Reports|May 2, 2022
Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control StudySara Denicolò, Verena Vogi, Felix Keller, et al.
Hypertension (Dallas, Tex. : 1979)|June 28, 2017
Proteomic-Biostatistic Integrated Approach for Finding the Underlying Molecular Determinants of Hypertension in Human PlasmaPrathibha R Gajjala, Vera Jankowski, Georg Heinze, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 23, 2009
Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustionPaul Jennings, Sonia Aydin, Jason Bennett, et al.
Diabetes Care|July 8, 2018
Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 DiabetesAndreas Heinzel, Michael Kammer, Gert Mayer, et al.
Cancer Letters|June 1, 2019
Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancerCaroline Kreuzinger, Isabel von der Decken, Andrea Wolf, et al.
Nature Communications|February 7, 2026
Urinary clusterin as a biomarker of human kidney disease progression and response to the endothelin receptor antagonist atrasentan: An exploratory analysis from the SONAR trialWenjun Ju, Viji Nair, Priya Vart, et al.
Kidney & Blood Pressure Research|November 7, 2024
Association of Urinary Epidermal Growth Factor, Fatty Acid-Binding Protein 3, and Vascular Cell Adhesion Molecule 1 Levels with the Progression of Early Diabetic Kidney DiseaseFelix Keller, Sara Denicolò, Johannes Leierer, et al.
Pageof 12